secwatch.observer — SEC 8-K summary
======================================

Issuer:     COGNITION THERAPEUTICS INC (CGTX)
CIK:        0001455365
Form:       8-K
Filed at:   2025-06-02T23:59:59+00:00
Accession:  0001104659-25-055089
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cognition Therapeutics files investor presentation on pathogenic oligomers approach
--------------------------------------------------------------------------------

- Filed investor presentation dated June 2025 under Item 8.01.
- Presentation focuses on targeting pathogenic oligomers for neurodegenerative diseases.
- No financial, clinical, or operational updates provided in the filing.
- Presentation may be used in discussions with investors and analysts.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1455365/000110465925055089/0001104659-25-055089-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1455365/000110465925055089/tm2516681d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-055089

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer